A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
AbbVie
Eli Lilly and Company
Shandong Suncadia Medicine Co., Ltd.
Pfizer
Jiangsu HengRui Medicine Co., Ltd.
AstraZeneca
AstraZeneca
Fred Hutchinson Cancer Center